Louis-Etienne Fortier

Louis-Étienne Fortier, CPA, is a member of the Board of Directors at Kainova Therapeutics. He has nearly 20 years of experience in finance, including more than a decade in private equity, growth investing, and financial advisory. His background spans investment leadership, transaction sourcing and capital deployment across the life sciences sector.

Mr. Fortier also currently serves as Managing Director, Investment, Life sciences at Investissement Québec, the province's leading economic development agency and investment corporation. In this role, he is responsible for a venture capital and growth equity portfolio that includes biotechnology, medtech, specialty pharmaceuticals, and life sciences service organizations.

Before joining Investissement Québec, Mr. Fortier held senior roles in private equity, corporate finance, and investment management. Earlier in his career, he worked in commercial banking and financial advisory, building a foundation in financial analysis and transactional support across diverse industries.

An active participant in the biotech community, Mr. Fortier holds multiple board and advisory positions, where he provides strategic guidance, operational expertise, and disciplined portfolio stewardship.

Mr. Fortier holds a Bachelor of Business Administration in Accounting from the Université de Sherbrooke. He is a Chartered Professional Accountant (CPA).